Delivery Order SPE2DB22D2206-SPE2DB23FKF69
Award Date 9/11/23
Potential Completion Date 9/12/23
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a medication used to reduce the risk of infection in cancer patients undergoing chemotherapy. The contract has a ceiling value of $13,074.00 and a completion date of July 10, 2025. It is a firm fixed-price contract, which indicates the price is...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,251.85, is for the delivery of Neulasta OnPro 6 mg/0.6 mL kits. This is a firm fixed-price delivery order with a completion date of June 5, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,389.54 to AmerisourceBergen Drug Corp for the supply of Neulasta Onpro 6 mg/0.6 ml injectable kits, with an ultimate completion date of December 4, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits to support U.S. government medical requirements. The $21,560.76 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under an existing Indefinite Delivery Contract (IDC) that has a total potential value of up to $999,999,999 for providing a comprehensive range of pharmaceutical and medical supplies to military treatment programs...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Neulasta OnPro 6 mg/0.6 ml kits. The order, valued at $6,176.80, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp provides pharmaceuticals, medical supplies, and related distribution services to support military treatment programs and facilities under an indefinite delivery...
- This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC is valued at $999,999,999 and runs through November 2026. This particular delivery order is for the pharmaceutical product NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, with a ceiling value of $10,059.36. The contract has a firm fixed price and is not designated as a set-aside. As a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,237.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Neulasta OnPro 6 mg/0.6 mL Kit on December 9, 2025, with a completion date of December 10, 2025. This non-set-aside competitive award is a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery will be performed at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a specialty medication. The contract has a ceiling value of $11,349.02 and a period of performance through November 19, 2024. This contract is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $1,214.78, for the supply of NEUPOGEN 300 MCG/ML VIALML. This medical product is likely used to support military healthcare programs. The contract has a period of performance through February...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a specialty pharmaceutical product. The contract has a firm fixed price of $17,160.11 and a period of performance through November 14, 2024. Amerisourcebergen is a major pharmaceutical distribution and healthcare solutions provider, and this contract is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA...